NeuroVasc Technologies
PrivateLast Round
Strategic
Feb 27, 2020
Total Funding Raised
$40.3M
Company Overview
NeuroVasc Technologies is a medical device company that develops a portfolio of novel catheter-based technologies to facilitate broad treatment options for patients suffering from stroke and other neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroVasc Technologies Comparables
Compare NeuroVasc Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vesalio | 92% | |
| Anaconda Biomed S.L. | 87% | |
| RapidPulse | 87% | |
NeuroVasc Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Feb 27, 2020 | ||||
| Series B | May 16, 2018 |
NeuroVasc Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ShangBay Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors increased 58% MoM.
- Jan 7, 2026
Monthly visitors grew 180% MoM, reaching 1.4K.
NeuroVasc Technologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroVasc Technologies's valuation, stock price, and market status.